The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .
Gastric Cancer
Progress free survival, 1 year|Disease-free surviva, 1 year
overall survival, 3 year|Objective Response Rate, 1 year|Disease Control Rate, 1 year
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .